BIO-KEY International adjourned its annual meeting and will reconvene it on October 2 after stockholders lacked enough votes on issuing up to 1,236,668 common shares upon Warrant exercise. The delay gives stockholders more time to consider the warrant-related proposal, while previously submitted votes remain valid unless holders choose to change them.

Key Highlights

  • A quorum attended BIO-KEY International’s annual meeting, but the warrant-related proposal lacked sufficient votes for approval.
  • The meeting’s Record Date remains July 15, 2026.
  • Stockholders who already voted and do not want to alter their choice need no further action.

BIO-KEY International Inc. (NASDAQ: BKYI) adjourned its 2026 annual meeting after stockholders did not have enough votes to approve issuance of up to 1,236,668 common shares upon exercise of warrants. The proposals remain unchanged.

Warrant Share Vote Moves to October 2

A quorum was present when the annual meeting convened on September 3, 2026. The proposal appeared in a supplement distributed after the original proxy statement, which was filed on July 24, 2026, and the supplement was filed on August 24, 2026. All polls remain open, and the record date continues to be July 15, 2026. BIO-KEY said no changes were made to the matters submitted for stockholder consideration.

Revised Proxies Required for Unvoted Shares

Stockholders who have not voted on the warrant-related measure must submit a new proxy using the revised proxy card previously distributed with the supplement, or vote through the available internet or telephone instructions. Holders who already submitted a proxy or otherwise voted do not need to act if they do not want to change their decision. BIO-KEY directed stockholders to review the proxy statement, supplement and other meeting materials before voting.